01 Executive Summary: Cost and Timeline Comparison
Build from Scratch
H4U Adaptation
Savings from Using H4U Platform
AI Medical Scribe | Voice Control | Mobile Apps | FHIR Integration | Telemedicine
02 Feature Comparison
| Category | Evrionta Requirement | H4U Status | Development Needed |
|---|---|---|---|
| Mobile Apps | iOS and Android | BASIC | Published, UI/UX refinement needed |
| Web Dashboard | Physician panel | BASIC | Metrics expansion, family network |
| FHIR Integration | SMART on FHIR | BASIC | Read available, field expansion + write-back |
| Wearables Sync | Apple Health, Google Fit | READY | None required |
| Voice Interface | Patient + physician control | READY | NLP expansion |
| AI Medical Scribe | Auto-documentation | READY | Family medicine adaptation |
| Telemedicine | Chat + AI agent | READY | Ready to use |
| Clinical Decision Support | Evidence-based | BASIC | Protocol library |
| Family Health Network | Genetic risk tracking | NEW | 4-5 months development |
| Care Team Coordination | Physician coordination | BASIC | 2-3 months |
| Pharma Engagement | CPM/CPC tracking | NEW | 3-4 months |
| Commerce Marketplace | E-commerce | NEW | 4-5 months |
| RWE Data Infrastructure | Data products | NEW | 3-4 months |
| HIPAA Compliance | Full readiness | FRAMEWORK | Audit, certification |
03 Detailed Budget Breakdown
TOTAL BUDGET: $8.0M FOR 12 MONTHS
| Category | Subcategory | Amount | Details |
|---|---|---|---|
| 1. DEVELOPMENT: $5.0M | |||
| Core Enhancement $3.5M |
Head of Engineering | $200K | CTO, architecture |
| 5 Backend Engineers | $885K | Phased: 3→5 (mo 1-6) | |
| 3 Frontend Engineers | $531K | Phased: 2→3 (mo 1-6) | |
| 4 Mobile Engineers | $708K | Phased: 2→4 (mo 1-12) | |
| DevOps Engineer | $177K | CI/CD, Infrastructure | |
| 4 QA Engineers | $636K | Phased: 2→4 (mo 1-12) | |
| Product Manager | $170K | Product strategy | |
| Product Designer | $150K | UX/UI design | |
| Infrastructure & Tools | $82K | AWS, tools | |
| TOTAL ENGINEERS | 17 (phased 11→17) | ||
| Pharma Infrastructure $500K |
VP Pharma Partnerships | $180K | Hired month 3 |
| Pharma Account Manager | $100K | Hired month 6 | |
| Medical Science Liaison | $120K | Clinical validation | |
| Development & Legal | $100K | CMS, MLR compliance | |
| Marketplace $360K |
Marketplace PM | $140K | E-commerce strategy |
| E-commerce Engineer | $130K | Development | |
| Supplier Partnership Mgr | $90K | Suppliers | |
| RWE Data $290K |
Data Engineer | $140K | Data warehouse |
| Clinical Data Scientist | $150K | RWE analytics | |
| GCC Adaptation | Localization + integration | $300K | Arabic, Thumbay EMR |
| 2. MARKETING & GROWTH: $800K | |||
| Team $475K |
VP Growth/Marketing | $170K | Growth strategy |
| Growth Marketing Manager | $120K | Physician acquisition | |
| Content Marketing Manager | $100K | Medical content | |
| Community Manager | $85K | Physician community | |
| Conferences GCC | Arab Health Dubai | $100K | Booths, sponsorships |
| Digital Marketing | LinkedIn, med publications | $120K | Physician targeting |
| KOL & Referrals | Advocate program | $105K | Influential physicians |
| 3. COMPLIANCE & REGULATORY: $900K | |||
| Team $300K |
Chief Compliance Officer | $120K | Part-time, mo. 6 |
| Data Protection Officer | $110K | GDPR/HIPAA | |
| Healthcare Attorney | $70K | Legal counsel | |
| Legal Documentation | ToS, Privacy, BAA | $90K | US + Israel + EU |
| HIPAA Compliance | Security assessment | $83K | Framework |
| Security Testing | Penetration testing | $135K | External experts |
| FDA Regulatory | Classification | $40K | FDA consultant |
| GCC Regulatory | UAE MOHAP, Saudi SFDA | $70K | Registration |
| Certifications | SOC 2 Type II | $50K | Audit prep |
| State Compliance | Medical board | $52K | TX, CA, NY |
| 4. FREE TIER RECURRING: $150K | |||
| AI/LLM API | Whisper + Claude | $45K | ~$14/physician/mo |
| Cloud Infrastructure | AWS hosting | $25K | ~$7/physician/mo |
| Third-party Services | FHIR, drug data, SMS | $60K | Redox, FDB, Twilio |
| Customer Support | Help desk | $20K | Intercom, materials |
| 5. THUMBAY INTEGRATION: $450K | |||
| Localization | Arabic UI/UX, NLP | $180K | RTL support |
| Thumbay EMR | Custom integration | $80K | Proprietary system |
| Thumbay Pharmacy API | Marketplace | $30K | 50+ pharmacies |
| Thumbay Labs | Diagnostics | $25K | Lab results |
| GCC Regulatory | UAE, Saudi, Qatar | $70K | MOHAP, SFDA |
| GCC Clinical Protocols | Diabetes, obesity | $40K | Local pathways |
| Cultural Adaptation | Prayer times, Ramadan | $25K | Cultural features |
| 6. CONTINGENCY: $800K (10%) | |||
| TOTAL SEED ROUND | $8.0M | ||
04 Team Structure & Hiring Timeline
MO 1-3 Startup Team (16)
GOAL: Launch H4U → Evrionta adaptation, Thumbay pilot
MO 4-6 Expansion (21)
GOAL: Thumbay rollout (100 physicians), pharma track, marketplace prep
MO 7-12 Full Team (25-27)
GOAL: All revenue streams (pharma, marketplace, RWE), GCC scaling
Organizational Structure (Full Team)
- Backend (5)
- Frontend (3)
- Mobile (4)
- Data Engineer (1)
- E-commerce (1)
- DevOps (1)
- QA (4)
- Core PM (1)
- Marketplace PM (1)
- Designer (1)
- VP Pharma (1)
- Pharma AM + MSL (2)
- Supplier PM (1)
- VP Growth + Team (3)
- CCO (1)
- DPO (1)
- Legal (1)
- Data Scientist (1)
05 Monthly Breakdown
NOTE: Total budget $8.0M includes $800K contingency (10%). Active spend = $7.2M.
PHASED HIRING: Mo 1-3: 16 people ($245K/month) → Mo 4-6: 21 people ($350K/month) → Mo 7-12: 27 people ($550K/month).
REVENUE OFFSET: By month 12, reaching $100K-125K MRR (~$1.2M-1.5M ARR run rate), partially offsetting burn rate. Total Year 1 Revenue: $370K-1.025M.
06 Timeline Comparison
Build from Scratch (18-24 months)
Basic Infrastructure
ACTIVITIES: Backend, DB design, API, mobile frameworks
TEAM: 20-25 engineers
RESULT: Platform skeleton, no clinical features
COST: ~$4.0M
Core Features
ACTIVITIES: FHIR, patient dashboard, wearables, AI Scribe from scratch
TEAM: 30-35 people
RESULT: MVP with basic workflows
COST: ~$5.0M
Advanced Features
ACTIVITIES: Family Network, Clinical Decision Support, coordination
TEAM: 40-45 people
RESULT: Full Evrionta functionality
COST: ~$3.5M
Monetization & Scaling
ACTIVITIES: Pharma, marketplace, RWE, compliance
TEAM: 45+ people
RESULT: Ready for commercial launch
COST: ~$2.5M
TOTAL FROM SCRATCH:
TIME: 18-24 months
COST: $15.0M
TEAM: 40-45 people peak
RISKS: Technical, timeline delays, regulatory, AI Scribe from scratch
H4U Adaptation (10-12 months)
Thumbay Pilot Setup
ACTIVITIES: H4U adaptation, Arabic, Thumbay EMR, 10 physician pilot
TEAM: 13-15 people
RESULT: Working pilot at Thumbay (UAE)
COST: ~$1.2M
AI MEDICAL SCRIBE ALREADY WORKING!
Feature Enrichment
ACTIVITIES: Family Network, Care Team, Thumbay rollout 100 physicians
TEAM: 16-17 people
RESULT: Core features validated in GCC
COST: ~$1.4M
GCC Expansion & Monetization
ACTIVITIES: Saudi Arabia, pharma, marketplace soft launch, contracts
TEAM: 20 people
RESULT: 200 physicians GCC, $80K MRR, business model proven
COST: ~$2.2M
Series A Preparation
ACTIVITIES: RWE data products, USA soft launch, Series A materials
TEAM: 20 people
RESULT: $100K-125K MRR, 100-125 physicians active, 3K-4K patients, Seed complete
COST: ~$1.1M
TOTAL H4U ADAPTATION:
TIME: 10-12 months
COST: $8.0M (saves $7.0M vs build from scratch)
TEAM: 16→21→27 phased (vs 45 for build from scratch)
RISKS: Reduced (ready platform, AI Scribe READY, Thumbay partnership)
07 Market Validation & ROI
MARKET COMPARABLES (2025-2026)
AI MEDICAL SCRIBE:
- Abridge: $5.3B valuation (Series E, $300M)
- Suki: $168M total funding (Series D $70M)
- Freed: 25,000+ clinicians, $99/month
HEALTHCARE AI BENCHMARKS:
- Median Series A: >$50M
- Median Series B: $143M
- Average round: $34.4M (83% premium vs non-AI)
- AI deals: 75% of health tech funding 2025
CLINICAL AI PLATFORMS:
- Hippocratic AI: $1.64B (Series B, $141M)
- OpenEvidence: $3.5B ($210M)
CHRONIC DISEASE MANAGEMENT:
- Virta: $2B (Series E) at $100M ARR
- Omada: $1.2B at IPO (2025) with 679K members
- Livongo: Acquired by Teladoc for $18.5B (2020)
REAL-WORLD EVIDENCE MARKET:
- Market: $4.74B (2024) → $10.83B (2030)
- CAGR: 14.8%
VALUATION & ROI PROJECTIONS
SEED ROUND (MONTHS 0-12):
- Investment: $6.6M
- Post-money valuation: $35-50M
- Target: 100-125 physicians active (MAU), 3K-4K patients, $100K-125K MRR
SERIES A (MONTHS 18-24):
- Projected valuation: $120-180M
- Target: 800-1,200 physicians, $5-10M ARR
- Rationale: Above median ($50M+), validated traction
SERIES B (MONTHS 30-36):
- Projected valuation: $500M-800M
- Target: 2,500 physicians, $30M ARR
- Rationale: Network effects, comparable to Virta ($2B at $100M ARR)
ROI FOR SEED INVESTOR:
- 15-25x return by Series B (24-36 months)
- Exit: Acquisition $1-2B or IPO $2-4B
* Projections based on 2025-2026 market comparables: AI healthcare median Series A >$50M, Series B $143M; comparable valuations Virta $2B, Hippocratic AI $1.64B, Abridge $5.3B
08 Executive Summary
EVRIONTA: H4U ADAPTATION + THUMBAY GROUP
FUNDING
$8.0M
Seed round for 12 months (vs $15M build from scratch)
TEAM
16→27
Phased growth (vs 40-45 build from scratch)
TARGET MRR M12
$100-125K
100-125 physicians MAU, 3-4K patients, 5 revenue streams
KEY MILESTONES:
- MO 3: Thumbay pilot validated (10 physicians, UAE)
- MO 6: Thumbay rollout complete (100 physicians, clinical validation)
- MO 10: First pharma contract ($50K pilot), 200 physicians GCC
- MO 12: Seed complete, Series A ready - 100-125 physicians MAU, 3-4K patients, $100-125K MRR
COMPETITIVE ADVANTAGES:
- AI MEDICAL SCRIBE + VOICE CONTROL: Production ready, full voice control
- THUMBAY PARTNERSHIP: 100+ physician captive base, pharmacy, university research
- GCC-FIRST: Lower regulatory barriers, proof-of-concept before USA
- PLATFORM ECONOMICS: FREE tier for physicians + pharma/marketplace/RWE
- NETWORK EFFECTS: More physicians → more data → more pharma revenue